194 related articles for article (PubMed ID: 27181518)
1. A pharmacological characterization of GABA, THIP and DS2 at binary α4β3 and β3δ receptors: GABA activates β3δ receptors via the β3(+)δ(-) interface.
Lee HJ; Absalom NL; Hanrahan JR; van Nieuwenhuijzen P; Ahring PK; Chebib M
Brain Res; 2016 Aug; 1644():222-30. PubMed ID: 27181518
[TBL] [Abstract][Full Text] [Related]
2. Low nanomolar GABA effects at extrasynaptic α4β1/β3δ GABA(A) receptor subtypes indicate a different binding mode for GABA at these receptors.
Karim N; Wellendorph P; Absalom N; Bang LH; Jensen ML; Hansen MM; Lee HJ; Johnston GA; Hanrahan JR; Chebib M
Biochem Pharmacol; 2012 Aug; 84(4):549-57. PubMed ID: 22658986
[TBL] [Abstract][Full Text] [Related]
3. High and low GABA sensitivity α4β2δ GABAA receptors are expressed in Xenopus laevis oocytes with divergent stoichiometries.
Hartiadi LY; Ahring PK; Chebib M; Absalom NL
Biochem Pharmacol; 2016 Mar; 103():98-108. PubMed ID: 26774457
[TBL] [Abstract][Full Text] [Related]
4. Potency of GABA at human recombinant GABA(A) receptors expressed in Xenopus oocytes: a mini review.
Karim N; Wellendorph P; Absalom N; Johnston GA; Hanrahan JR; Chebib M
Amino Acids; 2013 Apr; 44(4):1139-49. PubMed ID: 23385381
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of agonists at delta-containing GABAA receptors: Functional selectivity for extrasynaptic receptors is dependent on the absence of gamma2.
Stórustovu SI; Ebert B
J Pharmacol Exp Ther; 2006 Mar; 316(3):1351-9. PubMed ID: 16272218
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis for the high THIP/gaboxadol sensitivity of extrasynaptic GABA(A) receptors.
Meera P; Wallner M; Otis TS
J Neurophysiol; 2011 Oct; 106(4):2057-64. PubMed ID: 21795619
[TBL] [Abstract][Full Text] [Related]
7. Stigmasterol can be new steroidal drug for neurological disorders: Evidence of the GABAergic mechanism via receptor modulation.
Karim N; Khan I; Abdelhalim A; Halim SA; Khan A; Al-Harrasi A
Phytomedicine; 2021 Sep; 90():153646. PubMed ID: 34280827
[TBL] [Abstract][Full Text] [Related]
8. A study of subunit selectivity, mechanism and site of action of the delta selective compound 2 (DS2) at human recombinant and rodent native GABA(A) receptors.
Jensen ML; Wafford KA; Brown AR; Belelli D; Lambert JJ; Mirza NR
Br J Pharmacol; 2013 Mar; 168(5):1118-32. PubMed ID: 23061935
[TBL] [Abstract][Full Text] [Related]
9. Identification of a domain in the delta subunit (S238-V264) of the alpha4beta3delta GABAA receptor that confers high agonist sensitivity.
You H; Dunn SM
J Neurochem; 2007 Nov; 103(3):1092-101. PubMed ID: 17711419
[TBL] [Abstract][Full Text] [Related]
10. Etomidate, propofol and the neurosteroid THDOC increase the GABA efficacy of recombinant alpha4beta3delta and alpha4beta3 GABA A receptors expressed in HEK cells.
Meera P; Olsen RW; Otis TS; Wallner M
Neuropharmacology; 2009 Jan; 56(1):155-60. PubMed ID: 18778723
[TBL] [Abstract][Full Text] [Related]
11. Toward Understanding Functional Properties and Subunit Arrangement of α4β2δ γ-Aminobutyric Acid, Type A (GABAA) Receptors.
Wongsamitkul N; Baur R; Sigel E
J Biol Chem; 2016 Aug; 291(35):18474-83. PubMed ID: 27382064
[TBL] [Abstract][Full Text] [Related]
12. Probing α4βδ GABAA receptor heterogeneity: differential regional effects of a functionally selective α4β1δ/α4β3δ receptor agonist on tonic and phasic inhibition in rat brain.
Hoestgaard-Jensen K; Dalby NO; Krall J; Hammer H; Krogsgaard-Larsen P; Frølund B; Jensen AA
J Neurosci; 2014 Dec; 34(49):16256-72. PubMed ID: 25471566
[TBL] [Abstract][Full Text] [Related]
13. The interaction of general anaesthetics with recombinant GABAA and glycine receptors expressed in Xenopus laevis oocytes: a comparative study.
Pistis M; Belelli D; Peters JA; Lambert JJ
Br J Pharmacol; 1997 Dec; 122(8):1707-19. PubMed ID: 9422818
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of concatemeric GABA(A) receptors containing α4/δ subunits expressed in Xenopus oocytes.
Shu HJ; Bracamontes J; Taylor A; Wu K; Eaton MM; Akk G; Manion B; Evers AS; Krishnan K; Covey DF; Zorumski CF; Steinbach JH; Mennerick S
Br J Pharmacol; 2012 Apr; 165(7):2228-43. PubMed ID: 21950777
[TBL] [Abstract][Full Text] [Related]
15. The delta subunit of gamma-aminobutyric acid type A receptors does not confer sensitivity to low concentrations of ethanol.
Borghese CM; Stórustovu Sí; Ebert B; Herd MB; Belelli D; Lambert JJ; Marshall G; Wafford KA; Harris RA
J Pharmacol Exp Ther; 2006 Mar; 316(3):1360-8. PubMed ID: 16272217
[TBL] [Abstract][Full Text] [Related]
16. Development of a Robust Mammalian Cell-based Assay for Studying Recombinant α
Falk-Petersen CB; Søgaard R; Madsen KL; Klein AB; Frølund B; Wellendorph P
Basic Clin Pharmacol Toxicol; 2017 Aug; 121(2):119-129. PubMed ID: 28299900
[TBL] [Abstract][Full Text] [Related]
17. Etomidate, propofol and diazepam potentiate GABA-evoked GABAA currents in a cell line derived from human glioblastoma.
Babateen O; Jin Z; Bhandage A; Korol SV; Westermark B; Forsberg Nilsson K; Uhrbom L; Smits A; Birnir B
Eur J Pharmacol; 2015 Feb; 748():101-7. PubMed ID: 25510230
[TBL] [Abstract][Full Text] [Related]
18. Structure of alpha6 beta3 delta GABA(A) receptors and their lack of ethanol sensitivity.
Baur R; Kaur KH; Sigel E
J Neurochem; 2009 Dec; 111(5):1172-81. PubMed ID: 19765192
[TBL] [Abstract][Full Text] [Related]
19. Mutagenesis and computational docking studies support the existence of a histamine binding site at the extracellular β3+β3- interface of homooligomeric β3 GABAA receptors.
Hoerbelt P; Ramerstorfer J; Ernst M; Sieghart W; Thomson JL; Hough LB; Fleck MW
Neuropharmacology; 2016 Sep; 108():252-63. PubMed ID: 27140694
[TBL] [Abstract][Full Text] [Related]
20. A pharmacological assessment of agonists and modulators at α4β2γ2 and α4β2δ GABAA receptors: The challenge in comparing apples with oranges.
Ahring PK; Bang LH; Jensen ML; Strøbæk D; Hartiadi LY; Chebib M; Absalom N
Pharmacol Res; 2016 Sep; 111():563-576. PubMed ID: 27178730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
